MOG and myeloid sarcoma: MOG antibody-associated disease (MOGAD) has the same clinical characteristics as demyelinating diseases of the central nervous system, such as NMOSD and MS, but the difference is that its main manifestation is a monophasic or relapsing disease course, which has no marked sex or racial predominance in populations with MOGAD.